APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccines

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Selected research

Industry Growth & Trends

Global Oral Vaccines Industry Growth and Trends Forecast to 2032

2 January 2026114 pages

Choose your research edition.

Industry ResearchOral Vaccines Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccines Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Read the full market overview

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

Report Scope

This report provides a structured, data-driven view of the global Oral Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Vaccines Market by Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Segment by Type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Segment by Application

Public

Private

Oral Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rotavirus Vaccine Table 2. Major Company of Cholera Vaccine Table 3. Major Company of Oral Polio Vaccine Table 4. Global Oral Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 6. Global Oral Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Oral Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Oral Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 10. Global Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 11. Global Oral Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Oral Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Oral Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Oral Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 15. North America Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 16. North America Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 18. Europe Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Asia-Pacific Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 22. Latin America Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 24. Middle East and Africa Oral Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Oral Vaccines Industry Trends Table 26. Oral Vaccines Industry Drivers Table 27. Oral Vaccines Industry Opportunities and Challenges Table 28. Oral Vaccines Industry Restraints Table 29. Global Oral Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Oral Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Oral Vaccines Sales by Company (2021-2026) & (M Doses) Table 32. Global Oral Vaccines Sales Share by Company (2021-2026) Table 33. Global Oral Vaccines Market Price by Company (2021-2026) & (USD/K Doses) Table 34. Global Oral Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Oral Vaccines Major Company Production Sites and Headquarters Table 36. Global Oral Vaccines Company, Product Type & Application Table 37. Global Oral Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Oral Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses) Table 42. Global Oral Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Oral Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Oral Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 46. Global Oral Vaccines Sales by Region (2027-2032) & (M Doses) Table 47. Global Oral Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Oral Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Oral Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 51. Global Oral Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 53. Global Oral Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Oral Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Oral Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 57. Global Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 58. Global Oral Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Oral Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Oral Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Oral Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 62. North America Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 63. North America Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 65. Europe Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 67. Asia-Pacific Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 69. Latin America Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 71. Middle East and Africa Oral Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 75. Merck Oral Vaccines Product Portfolio Table 76. Merck Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 80. GSK Oral Vaccines Product Portfolio Table 81. GSK Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 85. Sanofi Oral Vaccines Product Portfolio Table 86. Sanofi Recent Development Table 87. Lanzhou Institute Company Information Table 88. Lanzhou Institute Business Overview Table 89. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 90. Lanzhou Institute Oral Vaccines Product Portfolio Table 91. Lanzhou Institute Recent Development Table 92. Serum Institute Company Information Table 93. Serum Institute Business Overview Table 94. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 95. Serum Institute Oral Vaccines Product Portfolio Table 96. Serum Institute Recent Development Table 97. Valneva Company Information Table 98. Valneva Business Overview Table 99. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 100. Valneva Oral Vaccines Product Portfolio Table 101. Valneva Recent Development Table 102. Shanghai United Cell Company Information Table 103. Shanghai United Cell Business Overview Table 104. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 105. Shanghai United Cell Oral Vaccines Product Portfolio Table 106. Shanghai United Cell Recent Development Table 107. Bibcol Company Information Table 108. Bibcol Business Overview Table 109. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 110. Bibcol Oral Vaccines Product Portfolio Table 111. Bibcol Recent Development Table 112. PaxVax Company Information Table 113. PaxVax Business Overview Table 114. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 115. PaxVax Oral Vaccines Product Portfolio Table 116. PaxVax Recent Development Table 117. Vabiotech Company Information Table 118. Vabiotech Business Overview Table 119. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 120. Vabiotech Oral Vaccines Product Portfolio Table 121. Vabiotech Recent Development Table 122. Tiantan Biological Company Information Table 123. Tiantan Biological Business Overview Table 124. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 125. Tiantan Biological Oral Vaccines Product Portfolio Table 126. Tiantan Biological Recent Development Table 127. EuBiologics Company Information Table 128. EuBiologics Business Overview Table 129. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 130. EuBiologics Oral Vaccines Product Portfolio Table 131. EuBiologics Recent Development Table 132. Panacea Biotec Ltd Company Information Table 133. Panacea Biotec Ltd Business Overview Table 134. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 135. Panacea Biotec Ltd Oral Vaccines Product Portfolio Table 136. Panacea Biotec Ltd Recent Development Table 137. Bio-Med Company Information Table 138. Bio-Med Business Overview Table 139. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 140. Bio-Med Oral Vaccines Product Portfolio Table 141. Bio-Med Recent Development Table 142. Halfkin Bio-Pharmaceuticals Company Information Table 143. Halfkin Bio-Pharmaceuticals Business Overview Table 144. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 145. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio Table 146. Halfkin Bio-Pharmaceuticals Recent Development Table 147. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 148. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 149. North America Oral Vaccines Sales Market Share by Country (2021-2026) Table 150. North America Oral Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 151. North America Oral Vaccines Sales Market Share Forecast by Country (2027-2032) Table 152. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Oral Vaccines Market Share by Country (2021-2026) Table 155. North America Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Oral Vaccines Market Share Forecast by Country (2027-2032) Table 157. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 158. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 159. Europe Oral Vaccines Sales Market Share by Country (2021-2026) Table 160. Europe Oral Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 161. Europe Oral Vaccines Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Oral Vaccines Market Share by Country (2021-2026) Table 165. Europe Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Oral Vaccines Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 169. Asia-Pacific Oral Vaccines Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Oral Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 171. Asia-Pacific Oral Vaccines Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Oral Vaccines Market Share by Country (2021-2026) Table 175. Asia-Pacific Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Oral Vaccines Market Share Forecast by Country (2027-2032) Table 177. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 178. Latin America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 179. Latin America Oral Vaccines Sales Market Share by Country (2021-2026) Table 180. Latin America Oral Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 181. Latin America Oral Vaccines Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Oral Vaccines Market Share by Country (2021-2026) Table 185. Latin America Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Oral Vaccines Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 189. Middle East and Africa Oral Vaccines Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Oral Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 191. Middle East and Africa Oral Vaccines Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Oral Vaccines Market Share by Country (2021-2026) Table 195. Middle East and Africa Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Oral Vaccines Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Oral Vaccines Distributors List Table 200. Oral Vaccines Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Oral Vaccines Image Figure 2. Global Oral Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Vaccines Sales (2021-2032) & (M Doses) Figure 5. Rotavirus Vaccine Image Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Cholera Vaccine Image Figure 8. Global Cholera Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Oral Polio Vaccine Image Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 11. Global Oral Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Oral Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Oral Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Oral Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Oral Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Oral Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Oral Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Oral Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Oral Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Oral Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Public Image Figure 26. Global Public Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Private Image Figure 28. Global Private Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Global Oral Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oral Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Oral Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Oral Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Oral Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Oral Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Oral Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Oral Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Oral Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Oral Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 42. North America Oral Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. Europe Oral Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Asia-Pacific Oral Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Latin America Oral Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Middle East and Africa Oral Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Oral Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Oral Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Applications
  • Public
  • Private
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Lanzhou Institute
  • Serum Institute
  • Valneva
  • Shanghai United Cell
  • Bibcol
  • PaxVax
  • Vabiotech
  • Tiantan Biological
  • EuBiologics
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Vaccines Market by Type
  6. 1.3.1 Rotavirus Vaccine
  7. 1.3.2 Cholera Vaccine
  8. 1.3.3 Oral Polio Vaccine
  9. 1.4 Global Oral Vaccines Market Size by Type
  10. 1.4.1 Global Oral Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Oral Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Oral Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Oral Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Oral Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Oral Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Oral Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Oral Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Vaccines Industry Trends
  2. 2.2 Oral Vaccines Industry Drivers
  3. 2.3 Oral Vaccines Industry Opportunities and Challenges
  4. 2.4 Oral Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Vaccines Price (2021-2026)
  4. 3.4 Global Oral Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Vaccines Company, Product Type & Application
  7. 3.7 Global Oral Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Vaccines Tier 1, Tier 2, and Tier 3
4 Oral Vaccines Regional Status and Outlook
  1. 4.1 Global Oral Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Vaccines Historic Market Size by Region
  3. 4.2.1 Global Oral Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Oral Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Vaccines by Application
  1. 5.1 Oral Vaccines Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Vaccines Market Size by Application
  5. 5.2.1 Global Oral Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Oral Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Oral Vaccines Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Oral Vaccines Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Lanzhou Institute
  20. 6.4.1 Lanzhou Institute Company Information
  21. 6.4.2 Lanzhou Institute Business Overview
  22. 6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
  24. 6.4.5 Lanzhou Institute Recent Developments
  25. 6.5 Serum Institute
  26. 6.5.1 Serum Institute Company Information
  27. 6.5.2 Serum Institute Business Overview
  28. 6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute Oral Vaccines Product Portfolio
  30. 6.5.5 Serum Institute Recent Developments
  31. 6.6 Valneva
  32. 6.6.1 Valneva Company Information
  33. 6.6.2 Valneva Business Overview
  34. 6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Valneva Oral Vaccines Product Portfolio
  36. 6.6.5 Valneva Recent Developments
  37. 6.7 Shanghai United Cell
  38. 6.7.1 Shanghai United Cell Company Information
  39. 6.7.2 Shanghai United Cell Business Overview
  40. 6.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
  42. 6.7.5 Shanghai United Cell Recent Developments
  43. 6.8 Bibcol
  44. 6.8.1 Bibcol Company Information
  45. 6.8.2 Bibcol Business Overview
  46. 6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bibcol Oral Vaccines Product Portfolio
  48. 6.8.5 Bibcol Recent Developments
  49. 6.9 PaxVax
  50. 6.9.1 PaxVax Company Information
  51. 6.9.2 PaxVax Business Overview
  52. 6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 PaxVax Oral Vaccines Product Portfolio
  54. 6.9.5 PaxVax Recent Developments
  55. 6.10 Vabiotech
  56. 6.10.1 Vabiotech Company Information
  57. 6.10.2 Vabiotech Business Overview
  58. 6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Vabiotech Oral Vaccines Product Portfolio
  60. 6.10.5 Vabiotech Recent Developments
  61. 6.11 Tiantan Biological
  62. 6.11.1 Tiantan Biological Company Information
  63. 6.11.2 Tiantan Biological Business Overview
  64. 6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
  66. 6.11.5 Tiantan Biological Recent Developments
  67. 6.12 EuBiologics
  68. 6.12.1 EuBiologics Company Information
  69. 6.12.2 EuBiologics Business Overview
  70. 6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 EuBiologics Oral Vaccines Product Portfolio
  72. 6.12.5 EuBiologics Recent Developments
  73. 6.13 Panacea Biotec Ltd
  74. 6.13.1 Panacea Biotec Ltd Company Information
  75. 6.13.2 Panacea Biotec Ltd Business Overview
  76. 6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
  78. 6.13.5 Panacea Biotec Ltd Recent Developments
  79. 6.14 Bio-Med
  80. 6.14.1 Bio-Med Company Information
  81. 6.14.2 Bio-Med Business Overview
  82. 6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Med Oral Vaccines Product Portfolio
  84. 6.14.5 Bio-Med Recent Developments
  85. 6.15 Halfkin Bio-Pharmaceuticals
  86. 6.15.1 Halfkin Bio-Pharmaceuticals Company Information
  87. 6.15.2 Halfkin Bio-Pharmaceuticals Business Overview
  88. 6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
  90. 6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Oral Vaccines Sales by Country
  2. 7.1.1 North America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Vaccines Market Size by Country
  6. 7.2.1 North America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Vaccines Sales by Country
  2. 8.1.1 Europe Oral Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Vaccines Market Size by Country
  6. 8.2.1 Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Oral Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Vaccines Sales by Country
  2. 10.1.1 South America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Vaccines Market Size by Country
  6. 10.2.1 South America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Oral Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Vaccines Value Chain Analysis
  2. 12.1.1 Oral Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Vaccines Production Mode & Process
  7. 12.2 Oral Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Vaccines Distributors
  10. 12.2.3 Oral Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst